Vertex Pharmaceuticals press releases
The latest press releases from Vertex Pharmaceuticals (NASDAQ: VRTX), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Vertex Pharmaceuticals release within minutes of publication.
- Listing
- NASDAQ: VRTX
- Latest release
- Nov 4, 2026
- On this page
- 20 newest releases
Latest Vertex Pharmaceuticals press releases
- Vertex to Participate in Upcoming Investor Conferences
BOSTON --(BUSINESS WIRE)--Nov. 4, 2026-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Susie Lisa, Senior Vice Pre…
- Vertex Reports Third Quarter 2026 Financial Results
— Achieved total revenue of $3.44 billion, a 12% increase compared to third quarter 2025 — — Raising full-year revenue guidance to $13.15 billion to $13.25 billion — — Established fourth commercial pi…
- Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept – - Data published in NEJM and presented at ASN high…
The first 3 are open to everyone. A free account shows the rest and emails you the next Vertex Pharmaceuticals release the minute it is out.
PPN World is independent and not affiliated with Vertex Pharmaceuticals. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Vertex Pharmaceuticals press releases?+
How do I get an alert when Vertex Pharmaceuticals publishes a press release?+
Is this Vertex Pharmaceuticals's official newsroom?+
Know the minute Vertex Pharmaceuticals publishes
Watch Vertex Pharmaceuticals, its competitors and its sector in one live feed, with email alerts — on the free plan.